Home News Latest News HPRA Drug Safety Newsletter Edition 93

HPRA Drug Safety Newsletter Edition 93

Home News Latest News HPRA Drug Safety Newsletter Edition 93
June 27, 2019

The 93rd edition of the HPRA Drug Safety Newsletter.

The 93rd edition of the HPRA Drug Safety Newsletter includes information on the following medicines:

  • Domperidone-containing medicines: No longer approved for use in children due to lack of efficacy

  • Direct oral anticoagulants (DOACs) are not recommended in patients with antiphopholipid syndrome (APS) due to possible increased risk of recurrent thrombotic events

  • Use of Xeljanz (tofacitinib) restricted in patients at high risk of pulmonary embolism whicle EMA review is ongoing.

The online versions of the DSN contains hyperlinks to product information and other documents on the HPRA and European Medicines Agency (EMA) websites, as appropriate.

Subscribe to our eZine

Receive our monthly newsletter with news and other content relevant to the Irish nursing and midwifery professions.